GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » bluebird bio Inc (NAS:BLUE) » Definitions » Cyclically Adjusted PB Ratio

bluebird bio (bluebird bio) Cyclically Adjusted PB Ratio : 0.04 (As of Jun. 09, 2024)


View and export this data going back to 2013. Start your Free Trial

What is bluebird bio Cyclically Adjusted PB Ratio?

As of today (2024-06-09), bluebird bio's current share price is $0.905. bluebird bio's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $22.06. bluebird bio's Cyclically Adjusted PB Ratio for today is 0.04.

The historical rank and industry rank for bluebird bio's Cyclically Adjusted PB Ratio or its related term are showing as below:

BLUE' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.04   Med: 0.19   Max: 0.72
Current: 0.04

During the past years, bluebird bio's highest Cyclically Adjusted PB Ratio was 0.72. The lowest was 0.04. And the median was 0.19.

BLUE's Cyclically Adjusted PB Ratio is ranked better than
94.1% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs BLUE: 0.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

bluebird bio's adjusted book value per share data for the three months ended in Sep. 2023 was $2.079. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $22.06 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


bluebird bio Cyclically Adjusted PB Ratio Historical Data

The historical data trend for bluebird bio's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bluebird bio Cyclically Adjusted PB Ratio Chart

bluebird bio Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.46 0.32

bluebird bio Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.32 0.14 0.15 0.14

Competitive Comparison of bluebird bio's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, bluebird bio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


bluebird bio's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bluebird bio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where bluebird bio's Cyclically Adjusted PB Ratio falls into.



bluebird bio Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

bluebird bio's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.905/22.06
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

bluebird bio's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, bluebird bio's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=2.079/129.8595*129.8595
=2.079

Current CPI (Sep. 2023) = 129.8595.

bluebird bio Quarterly Data

Book Value per Share CPI Adj_Book
201312 6.335 98.326 8.367
201403 5.938 99.695 7.735
201406 6.610 100.560 8.536
201409 9.125 100.428 11.799
201412 15.190 99.070 19.911
201503 14.514 99.621 18.919
201506 25.557 100.684 32.963
201509 24.263 100.392 31.385
201512 23.052 99.792 29.997
201603 21.835 100.470 28.222
201606 20.520 101.688 26.205
201609 18.622 101.861 23.741
201612 21.367 101.863 27.240
201703 19.925 102.862 25.155
201706 26.351 103.349 33.110
201709 24.928 104.136 31.086
201712 32.859 104.011 41.025
201803 31.362 105.290 38.681
201806 29.020 106.317 35.446
201809 36.592 106.507 44.615
201812 34.438 105.998 42.190
201903 32.180 107.251 38.964
201906 29.629 108.070 35.603
201909 26.604 108.329 31.891
201912 23.208 108.420 27.797
202003 20.144 108.902 24.021
202006 25.410 108.767 30.338
202009 22.958 109.815 27.149
202012 20.398 109.897 24.103
202103 17.803 111.754 20.687
202106 14.575 114.631 16.511
202109 12.419 115.734 13.935
202112 5.263 117.630 5.810
202203 3.685 121.301 3.945
202206 2.449 125.017 2.544
202209 1.917 125.227 1.988
202212 2.368 125.222 2.456
202303 3.335 127.348 3.401
202306 2.715 128.729 2.739
202309 2.079 129.860 2.079

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


bluebird bio  (NAS:BLUE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


bluebird bio Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of bluebird bio's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


bluebird bio (bluebird bio) Business Description

Industry
Traded in Other Exchanges
Address
455 Grand Union Boulevard, Somerville, MA, USA, 02145
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Executives
Richard A Colvin officer: Chief Medical Officer 455 GRAND UNION BOULEVARD, C/O BLUEBIRD BIO, INC., SOMERVILLE MA 02145
Andrew Obenshain officer: President of SGD C/O BLUEBIRD BIO, INC., 455 GRAND UNION BOULEVARD, SOMERVILLE MA 02145
Christopher Krawtschuk officer: Chief Financial Officer 455 GRAND UNION BOULEVARD, C/O BLUEBIRD BIO, INC., SOMERVILLE MA 02145
Thomas J Klima officer: Chief Commercial Officer, SGD C/O BLUEBIRD BIO, INC., 455 GRAND UNION BOULEVARD, SOMERVILLE MA 02145
Richard A. Paulson director 85 WELLS AVENUE, NEWTON MA 02459
Nick Leschly director, officer: President and CEO C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Joseph Vittiglio officer: Chief Business & Legal Officer C/O BLUEBIRD BIO, INC., 455 GRAND UNION BLVD, SOMERVILLE MA 02145
Elisabeth Leiderman director 1325 BOYLSTON STREET, SUITE 500, BOSTON MA 02215
Jason Cole officer: SVP, Secy. & General Counsel C/O BLUEBIRD BIO, INC, 455 GRAND UNION BOULEVARD, SOMERVILLE MA 02145
Anne-virginie Eggimann officer: Chief Regulatory Officer C/O CODIAK BIOSCIENCES, INC., 35 CAMBRIDGEPARK DRIVE, SUITE 500, CAMBRIDGE MA 02140
Charlotte Jones-burton director 455 GRAND UNION BOULEVARD, C/O BLUEBIRD BIO, INC., SOMERVILLE MA 02145
Gina Consylman officer: Chief Financial Officer C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON MA 02110
Jessica Whitten officer: Chief Accounting Officer 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
Sarah Js Glickman director 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
Najoh Tita-reid director 455 GRAND UNION BOULEVARD, C/O BLUEBIRD BIO, INC., SOMERVILLE MA 02145

bluebird bio (bluebird bio) Headlines

From GuruFocus

bluebird bio, Inc. Announces Proposed Public Offering of Common Stock

By Business Wire Business Wire 01-18-2023